Vous êtes ici

Home › Inscriptions › Sciences Biologiques › Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals Inc.

Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Life Sciences
Symbole: 
AGN
Associated Securities: 
Algernon Pharmaceuticals Inc. - Warrants
Indice CSE: 
Devise: 

Vous êtes ici

Accueil

Algernon Pharmaceuticals Inc. (AGN)

SEDAR Information

Formulaire de recherche

Information d'entreprise

Addresse
789 West Pender St., Suite 890
Vancouver, BC V6C 1H2
Canada
Téléphone
604-646-1553
Courriel
k.malhi@dccnet.com
Date d’inscription à la cote
Lundi, février 1, 2016
Vérificateur
James Stafford Inc.

Advertisement

Publicité

Capitalisation

Capitalisation: 
166,556,769
Réservé à l'émission: 
54,407,694

Communiqués de presse

21/10/2021

Algernon Pharmaceuticals Announces Receipt of CAD$2M Cash Refund from Australian Research Program and Files Application to List its Common Shares on Nasdaq Capital Market

13/10/2021

Algernon Files Meeting Request with MHRA for Use of DMT in Phase 1/2a Human Stroke Study

Bulletins

19/01/2021

2021-0122 - Expiration - Algernon Pharmaceuticals Inc. - Warrants (AGN.WT)

le 19 janvier/January 2021

Further to Bulletin 2020-1240, Algernon Pharmaceuticals Inc. warrants will expire on January 21, 2021.

Settlement Terms:  All trades January 19th and 20th  will settle for cash next day. Trades on January 21 will be for cash same day.

The warrants will be halted at noon and delisted at market close January 21, 2021.

Dépôts CSE

Algernon Pharmaceuticals - Form 7 Monthly Report (September 2021)

Algernon Pharmaceuticals - Form 7 Monthly Report (August 2021)

Algernon Pharmaceuticals - Form 7 Monthly Report (July 2021)

Algernon Pharmaceuticals - CEO certificate for quarter ended May 31, 2021

Algernon Pharmaceuticals - CFO certificate for quarter ended May 31, 2021

Advertisement

Publicité

Latest CSE News